NCT01058655 2017-04-13RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal CancerDana-Farber Cancer InstitutePhase 1/2 Completed56 enrolled 15 charts
NCT01478594 2015-07-08A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line TherapyAVEO Pharmaceuticals, Inc.Phase 2 Completed265 enrolled 34 charts